CSPC Innovation Pharmaceutical Co., Ltd.
300765
Rank in Stocks
#2325
Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical... Operating from its base in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. specializes in the manufacturing and commercialization of caffeine, vitamin C, health supplements, and various beverage offerings. The company functions as a subsidiary of the larger entity, CSPC Pharmaceutical Group Limited.
Share Price
$6.59
Market Cap
$8.36B
Change (1 day)
-5.40%
Change (1 year)
14.66%
Country
CN
Trade CSPC Innovation Pharmaceutical Co., Ltd. (300765)
Category
Consumer Defensive
P/B ratio for CSPC Innovation Pharmaceutical Co., Ltd. (300765)
P/B ratio as of October 2026 TTM: 15.56
According to CSPC Innovation Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 15.56. At the end of 2024 the company had a P/B ratio of 9.97.
P/B ratio history for CSPC Innovation Pharmaceutical Co., Ltd. from 2014 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 15.56 | -17.36% |
| 2025 | 18.83 | 88.84% |
| 2024 | 9.97 | 18.96% |
| 2023 | 8.38 | 237.63% |
| 2022 | 2.48 | -22.79% |
| 2021 | 3.22 | 9.80% |
| 2020 | 2.93 | 5.41% |
| 2019 | 2.78 | -48.03% |
| 2018 | 5.35 | -22.43% |
| 2017 | 6.89 | -25.32% |
| 2016 | 9.23 | 8.97% |
| 2015 | 8.47 | -35.62% |
| 2014 | 13.15 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 7.4584 | -52.07% |
CH
|
|
| 2.2466 | -85.56% |
FR
|
|
| 6.231 | -59.96% |
JP
|
|
| 2.3789 | -84.71% |
BR
|
|
| 0.7994 | -94.86% |
US
|
